Abstract |
MAGNE-B6 was used for the therapy of a group of 31 children aged from 6 to 12 with attention deficiency and hyperactivity syndrome. The control group included 20 children with similar manifestations of the same pathology, which received a polyvitamin complex. The efficacy of therapy was assessed in the 30th day with the aid of a complex clinical-neuropsychological and biochemical investigations. It was established that the administration of MAGNE-B6 led to improvements in the behavior, decreased the level of anxiety and aggression, improved both large- and small-scale mobility, decreased the level of synkinesis, increased the characteristics of attention, corrected the magnesium homeostasis, and favored normalization of the blood electrolytes. Reliable differences (p < 0.01 or 0.001) between the test and control groups in the degree of expression of the indicated disorders were observed.
|
Authors | O R Nogovitsina, E V Levitina |
Journal | Eksperimental'naia i klinicheskaia farmakologiia
(Eksp Klin Farmakol)
2006 Jan-Feb
Vol. 69
Issue 1
Pg. 74-7
ISSN: 0869-2092 [Print] Russia (Federation) |
PMID | 16579066
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Drug Combinations
- Magne B6
- Vitamin B 6
- Ca(2+) Mg(2+)-ATPase
- magnesium sodium potassium ATPase
- Sodium-Potassium-Exchanging ATPase
- Magnesium
- Ascorbic Acid
- Calcium
|
Topics |
- Ascorbic Acid
(therapeutic use)
- Attention
(drug effects)
- Attention Deficit Disorder with Hyperactivity
(blood, drug therapy, psychology)
- Biological Transport
- Ca(2+) Mg(2+)-ATPase
(metabolism)
- Calcium
(blood)
- Child
- Drug Combinations
- Erythrocytes
(drug effects, metabolism)
- Female
- Humans
- Magnesium
(administration & dosage, blood, therapeutic use)
- Male
- Neuropsychological Tests
- Sodium-Potassium-Exchanging ATPase
(metabolism)
- Surveys and Questionnaires
- Vitamin B 6
(administration & dosage, therapeutic use)
|